Mission Produce (AVO) Q3 2026 Earnings Call Transcript

Mission Produce reported fiscal Q3 revenue of $450 million, up 26% year over year, and adjusted EBITDA of $32.4 million, above its $28 million-$32 million guidance range. The company raised expected annualized Calavo acquisition synergies to more than $30 million from at least $25 million and reaffirmed second-half EBITDA guidance of $84 million-$88 million, implying Q4 EBITDA of $52 million-$55 million. Results remain tempered by a $6.5 million GAAP net loss, 270bps gross-margin compression to 9.9%, lower avocado pricing, and acquisition-related debt of roughly $400.3 million.

Analysis

AVO’s rerating hinges less on reported EBITDA and more on proving that acquired scale converts into cash after integration spending, working-capital swings, capex, and a substantially higher interest burden. The key second-order benefit is procurement and freight density: a combined sourcing/packing network should reduce spot-market fruit purchases and empty-mile logistics, making AVO more resilient than smaller produce distributors when regional crop timing becomes dislocated. Conversely, greater buyer concentration with grocers could limit how much of that operating leverage is retained rather than passed through in price.

The next 30-60 days are dominated by Q4 execution, where a high seasonal earnings concentration raises the downside from any shipment delay, European pricing weakness, fruit-quality issue, or blueberry yield miss. Management’s synergy increase is not yet equivalent to realized savings; the relevant KPI at the Investor Day and FY27 guidance is quarterly run-rate savings net of incremental systems, severance, plant-rationalization, and customer-retention costs. Continued repurchases while leverage remains elevated would be a negative capital-allocation signal and could cap multiple expansion.

Consensus may underappreciate the strategic value of multi-origin supply during supply shocks, but it may also be extrapolating a favorable harvest mix into a normalized margin base. AVO is becoming a more operationally levered, lower-margin integration story, not simply a consumption-growth story; that supports upside only if management demonstrates debt reduction and cash conversion alongside synergies. CVGW is no longer a viable standalone hedge following the completed acquisition, so the cleaner comparison is AVO versus broad consumer-staples exposure rather than an announced-deal pair.

Key Decisions for Investors

• Initiate a small long AVO only after Q4 results confirm the seasonal EBITDA exit rate and management quantifies FY27 realized synergies; target a 6-12 month holding period. Underwrite 2:1 upside/downside only if operating cash flow turns positive in Q4 and net debt begins declining.
• Use the upcoming Investor Day as a catalyst watch: add on a disclosed quarterly synergy run-rate of at least $7.5 million by late FY27, a credible capex normalization path, and no material customer attrition. Avoid adding on headline synergy targets without a cash-cost bridge.
• Set a hard thesis review trigger if Q4 EBITDA misses the guided range, Peru/blueberry realization weakens, or FY27 interest expense rises despite stated deleveraging priorities; any of these would expose that acquisition economics are being supported by favorable seasonal mix rather than durable efficiency.
• Do not pursue a long AVO/short CVGW pair: CVGW’s standalone equity exposure should have been eliminated by the transaction. For portfolio hedging, pair a tactical AVO long with a modest short in XLP only if the objective is to isolate company-specific integration upside from broad defensive-factor moves.